Targeting the immune-suppressive tumor microenvironment to potentiate CAR T cell therapy Article Swipe
Tiffany C. Y. Tang
,
Ning Xu
,
Alla Dolnikov
·
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.15761/crr.1000203
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.15761/crr.1000203
Chimeric antigen receptor (CAR) T cell therapy is a promising new immunotherapy that reprograms patient T lymphocytes to specifically recognize and kill tumor cells.CAR T cell therapy has produced some dramatic responses in acute lymphoblastic leukemia and lymphomas, but responses have been less spectacular in solid tumors.To make CAR T cell therapy effective for solid tumors, CAR T cells must overcome an immune-suppressive tumor microenvironment (TME) that attenuates CAR T cell function.This review provides insights into mechanisms of CAR T cell therapy resistance with respect to the TME and offers strategies for improving CAR T cell therapy by targeting immune-suppressive factors in tumors.
Related Topics
Concepts
Tumor microenvironment
Immune system
CAR T-cell therapy
Cancer research
T cell
Medicine
Immunology
Chimeric antigen receptor
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.15761/crr.1000203
- https://www.oatext.com/pdf/CRR-4-203.pdf
- OA Status
- diamond
- Cited By
- 2
- References
- 95
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3033535133
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3033535133Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.15761/crr.1000203Digital Object Identifier
- Title
-
Targeting the immune-suppressive tumor microenvironment to potentiate CAR T cell therapyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2020Year of publication
- Publication date
-
2020-01-01Full publication date if available
- Authors
-
Tiffany C. Y. Tang, Ning Xu, Alla DolnikovList of authors in order
- Landing page
-
https://doi.org/10.15761/crr.1000203Publisher landing page
- PDF URL
-
https://www.oatext.com/pdf/CRR-4-203.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://www.oatext.com/pdf/CRR-4-203.pdfDirect OA link when available
- Concepts
-
Tumor microenvironment, Immune system, CAR T-cell therapy, Cancer research, T cell, Medicine, Immunology, Chimeric antigen receptorTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2022: 1Per-year citation counts (last 5 years)
- References (count)
-
95Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3033535133 |
|---|---|
| doi | https://doi.org/10.15761/crr.1000203 |
| ids.doi | https://doi.org/10.15761/crr.1000203 |
| ids.mag | 3033535133 |
| ids.openalex | https://openalex.org/W3033535133 |
| fwci | 0.10058779 |
| type | article |
| title | Targeting the immune-suppressive tumor microenvironment to potentiate CAR T cell therapy |
| biblio.issue | 1 |
| biblio.volume | 4 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11491 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | CAR-T cell therapy research |
| topics[1].id | https://openalex.org/T12255 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.98089998960495 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2403 |
| topics[1].subfield.display_name | Immunology |
| topics[1].display_name | Biosimilars and Bioanalytical Methods |
| topics[2].id | https://openalex.org/T11016 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.970300018787384 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2741 |
| topics[2].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[2].display_name | Monoclonal and Polyclonal Antibodies Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2776107976 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7222414612770081 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1786433 |
| concepts[0].display_name | Tumor microenvironment |
| concepts[1].id | https://openalex.org/C8891405 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6046337485313416 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[1].display_name | Immune system |
| concepts[2].id | https://openalex.org/C2911194787 |
| concepts[2].level | 5 |
| concepts[2].score | 0.5034727454185486 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q5099363 |
| concepts[2].display_name | CAR T-cell therapy |
| concepts[3].id | https://openalex.org/C502942594 |
| concepts[3].level | 1 |
| concepts[3].score | 0.4810669422149658 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[3].display_name | Cancer research |
| concepts[4].id | https://openalex.org/C2776090121 |
| concepts[4].level | 3 |
| concepts[4].score | 0.4368991255760193 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q193529 |
| concepts[4].display_name | T cell |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.41533878445625305 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C203014093 |
| concepts[6].level | 1 |
| concepts[6].score | 0.4010867476463318 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[6].display_name | Immunology |
| concepts[7].id | https://openalex.org/C3875195 |
| concepts[7].level | 4 |
| concepts[7].score | 0.1928502917289734 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q5099363 |
| concepts[7].display_name | Chimeric antigen receptor |
| keywords[0].id | https://openalex.org/keywords/tumor-microenvironment |
| keywords[0].score | 0.7222414612770081 |
| keywords[0].display_name | Tumor microenvironment |
| keywords[1].id | https://openalex.org/keywords/immune-system |
| keywords[1].score | 0.6046337485313416 |
| keywords[1].display_name | Immune system |
| keywords[2].id | https://openalex.org/keywords/car-t-cell-therapy |
| keywords[2].score | 0.5034727454185486 |
| keywords[2].display_name | CAR T-cell therapy |
| keywords[3].id | https://openalex.org/keywords/cancer-research |
| keywords[3].score | 0.4810669422149658 |
| keywords[3].display_name | Cancer research |
| keywords[4].id | https://openalex.org/keywords/t-cell |
| keywords[4].score | 0.4368991255760193 |
| keywords[4].display_name | T cell |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.41533878445625305 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/immunology |
| keywords[6].score | 0.4010867476463318 |
| keywords[6].display_name | Immunology |
| keywords[7].id | https://openalex.org/keywords/chimeric-antigen-receptor |
| keywords[7].score | 0.1928502917289734 |
| keywords[7].display_name | Chimeric antigen receptor |
| language | en |
| locations[0].id | doi:10.15761/crr.1000203 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210182880 |
| locations[0].source.issn | 2513-9290 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2513-9290 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Cancer Reports and Reviews |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.oatext.com/pdf/CRR-4-203.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Cancer Reports and Reviews |
| locations[0].landing_page_url | https://doi.org/10.15761/crr.1000203 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5087867370 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-1399-365X |
| authorships[0].author.display_name | Tiffany C. Y. Tang |
| authorships[0].countries | AU |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I31746571 |
| authorships[0].affiliations[0].raw_affiliation_string | Children's Cancer Institute, University of New South Wales, Sydney, Australia |
| authorships[0].institutions[0].id | https://openalex.org/I31746571 |
| authorships[0].institutions[0].ror | https://ror.org/03r8z3t63 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I31746571 |
| authorships[0].institutions[0].country_code | AU |
| authorships[0].institutions[0].display_name | UNSW Sydney |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Tiffany C. Y. Tang |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Children's Cancer Institute, University of New South Wales, Sydney, Australia |
| authorships[1].author.id | https://openalex.org/A5101686130 |
| authorships[1].author.orcid | https://orcid.org/0009-0005-1599-2369 |
| authorships[1].author.display_name | Ning Xu |
| authorships[1].countries | AU |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210125633 |
| authorships[1].affiliations[0].raw_affiliation_string | Kids Cancer Center, Sydney Children's Hospital, Sydney, Australia |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I31746571 |
| authorships[1].affiliations[1].raw_affiliation_string | Children's Cancer Institute, University of New South Wales, Sydney, Australia |
| authorships[1].institutions[0].id | https://openalex.org/I4210125633 |
| authorships[1].institutions[0].ror | https://ror.org/02tj04e91 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210125633, https://openalex.org/I4210149013 |
| authorships[1].institutions[0].country_code | AU |
| authorships[1].institutions[0].display_name | Sydney Children's Hospital |
| authorships[1].institutions[1].id | https://openalex.org/I31746571 |
| authorships[1].institutions[1].ror | https://ror.org/03r8z3t63 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I31746571 |
| authorships[1].institutions[1].country_code | AU |
| authorships[1].institutions[1].display_name | UNSW Sydney |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ning Xu |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Children's Cancer Institute, University of New South Wales, Sydney, Australia, Kids Cancer Center, Sydney Children's Hospital, Sydney, Australia |
| authorships[2].author.id | https://openalex.org/A5077161506 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Alla Dolnikov |
| authorships[2].countries | AU |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210125633 |
| authorships[2].affiliations[0].raw_affiliation_string | Kids Cancer Center, Sydney Children's Hospital, Sydney, Australia |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I31746571 |
| authorships[2].affiliations[1].raw_affiliation_string | Children's Cancer Institute, University of New South Wales, Sydney, Australia |
| authorships[2].institutions[0].id | https://openalex.org/I4210125633 |
| authorships[2].institutions[0].ror | https://ror.org/02tj04e91 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210125633, https://openalex.org/I4210149013 |
| authorships[2].institutions[0].country_code | AU |
| authorships[2].institutions[0].display_name | Sydney Children's Hospital |
| authorships[2].institutions[1].id | https://openalex.org/I31746571 |
| authorships[2].institutions[1].ror | https://ror.org/03r8z3t63 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I31746571 |
| authorships[2].institutions[1].country_code | AU |
| authorships[2].institutions[1].display_name | UNSW Sydney |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | Alla Dolnikov |
| authorships[2].is_corresponding | True |
| authorships[2].raw_affiliation_strings | Children's Cancer Institute, University of New South Wales, Sydney, Australia, Kids Cancer Center, Sydney Children's Hospital, Sydney, Australia |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.oatext.com/pdf/CRR-4-203.pdf |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Targeting the immune-suppressive tumor microenvironment to potentiate CAR T cell therapy |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11491 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | CAR-T cell therapy research |
| related_works | https://openalex.org/W4307869277, https://openalex.org/W4211132779, https://openalex.org/W2955300884, https://openalex.org/W1972945471, https://openalex.org/W2357948923, https://openalex.org/W4313472242, https://openalex.org/W2030500189, https://openalex.org/W2144422987, https://openalex.org/W2419188526, https://openalex.org/W4317738354 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2022 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 1 |
| best_oa_location.id | doi:10.15761/crr.1000203 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210182880 |
| best_oa_location.source.issn | 2513-9290 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2513-9290 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Cancer Reports and Reviews |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.oatext.com/pdf/CRR-4-203.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Cancer Reports and Reviews |
| best_oa_location.landing_page_url | https://doi.org/10.15761/crr.1000203 |
| primary_location.id | doi:10.15761/crr.1000203 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210182880 |
| primary_location.source.issn | 2513-9290 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2513-9290 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Cancer Reports and Reviews |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.oatext.com/pdf/CRR-4-203.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Cancer Reports and Reviews |
| primary_location.landing_page_url | https://doi.org/10.15761/crr.1000203 |
| publication_date | 2020-01-01 |
| publication_year | 2020 |
| referenced_works | https://openalex.org/W4230391764, https://openalex.org/W2398350456, https://openalex.org/W4211246989, https://openalex.org/W2251447490, https://openalex.org/W2754465613, https://openalex.org/W2129644533, https://openalex.org/W2967973649, https://openalex.org/W2885702195, https://openalex.org/W2800191102, https://openalex.org/W2561662975, https://openalex.org/W2504729294, https://openalex.org/W2343776099, https://openalex.org/W2143145234, https://openalex.org/W1832259511, https://openalex.org/W2122415351, https://openalex.org/W2969586911, https://openalex.org/W2131878959, https://openalex.org/W2128497896, https://openalex.org/W2994323662, https://openalex.org/W2755078225, https://openalex.org/W2000138369, https://openalex.org/W1987165863, https://openalex.org/W2395322328, https://openalex.org/W1630847696, https://openalex.org/W2765902946, https://openalex.org/W2912325942, https://openalex.org/W2039092335, https://openalex.org/W2137049683, https://openalex.org/W1979936799, https://openalex.org/W2296829012, https://openalex.org/W2113053092, https://openalex.org/W2064272625, https://openalex.org/W2171114996, https://openalex.org/W2801203250, https://openalex.org/W2050698267, https://openalex.org/W2801709171, https://openalex.org/W2099570622, https://openalex.org/W2921873774, https://openalex.org/W2734515449, https://openalex.org/W2119088830, https://openalex.org/W1556687169, https://openalex.org/W1935207452, https://openalex.org/W2042967471, https://openalex.org/W1978541343, https://openalex.org/W2784242077, https://openalex.org/W2124513722, https://openalex.org/W2105400883, https://openalex.org/W2790543400, https://openalex.org/W2121080857, https://openalex.org/W2330978427, https://openalex.org/W4298239970, https://openalex.org/W2118796952, https://openalex.org/W2735691291, https://openalex.org/W2097074641, https://openalex.org/W2129702476, https://openalex.org/W2944501574, https://openalex.org/W2072041272, https://openalex.org/W2155081123, https://openalex.org/W2112680373, https://openalex.org/W2773804840, https://openalex.org/W2901478468, https://openalex.org/W1675343160, https://openalex.org/W2800926996, https://openalex.org/W2799436632, https://openalex.org/W2903225254, https://openalex.org/W2611086649, https://openalex.org/W2062761137, https://openalex.org/W2787301955, https://openalex.org/W2301169192, https://openalex.org/W1990061395, https://openalex.org/W1988224215, https://openalex.org/W2787621143, https://openalex.org/W4237462032, https://openalex.org/W2606654718, https://openalex.org/W1971915168, https://openalex.org/W2342880373, https://openalex.org/W2900662379, https://openalex.org/W2104065243, https://openalex.org/W2602369513, https://openalex.org/W2121792973, https://openalex.org/W2917856590, https://openalex.org/W2500107307, https://openalex.org/W2090355105, https://openalex.org/W2566254990, https://openalex.org/W2566677727, https://openalex.org/W1994112690, https://openalex.org/W2989444723, https://openalex.org/W2130338247, https://openalex.org/W4238041119, https://openalex.org/W2339389594, https://openalex.org/W4233267089, https://openalex.org/W2110271242, https://openalex.org/W2342423058, https://openalex.org/W2142169541, https://openalex.org/W2012405690 |
| referenced_works_count | 95 |
| abstract_inverted_index.T | 4, 15, 24, 49, 57, 69, 79, 94 |
| abstract_inverted_index.a | 8 |
| abstract_inverted_index.an | 61 |
| abstract_inverted_index.by | 97 |
| abstract_inverted_index.in | 32, 44, 101 |
| abstract_inverted_index.is | 7 |
| abstract_inverted_index.of | 77 |
| abstract_inverted_index.to | 17, 85 |
| abstract_inverted_index.CAR | 48, 56, 68, 78, 93 |
| abstract_inverted_index.TME | 87 |
| abstract_inverted_index.and | 20, 36, 88 |
| abstract_inverted_index.but | 38 |
| abstract_inverted_index.for | 53, 91 |
| abstract_inverted_index.has | 27 |
| abstract_inverted_index.new | 10 |
| abstract_inverted_index.the | 86 |
| abstract_inverted_index.been | 41 |
| abstract_inverted_index.cell | 5, 25, 50, 70, 80, 95 |
| abstract_inverted_index.have | 40 |
| abstract_inverted_index.into | 75 |
| abstract_inverted_index.kill | 21 |
| abstract_inverted_index.less | 42 |
| abstract_inverted_index.make | 47 |
| abstract_inverted_index.must | 59 |
| abstract_inverted_index.some | 29 |
| abstract_inverted_index.that | 12, 66 |
| abstract_inverted_index.with | 83 |
| abstract_inverted_index.(CAR) | 3 |
| abstract_inverted_index.(TME) | 65 |
| abstract_inverted_index.acute | 33 |
| abstract_inverted_index.cells | 58 |
| abstract_inverted_index.solid | 45, 54 |
| abstract_inverted_index.tumor | 22, 63 |
| abstract_inverted_index.offers | 89 |
| abstract_inverted_index.review | 72 |
| abstract_inverted_index.antigen | 1 |
| abstract_inverted_index.factors | 100 |
| abstract_inverted_index.patient | 14 |
| abstract_inverted_index.respect | 84 |
| abstract_inverted_index.therapy | 6, 26, 51, 81, 96 |
| abstract_inverted_index.tumors, | 55 |
| abstract_inverted_index.tumors. | 102 |
| abstract_inverted_index.Chimeric | 0 |
| abstract_inverted_index.dramatic | 30 |
| abstract_inverted_index.insights | 74 |
| abstract_inverted_index.leukemia | 35 |
| abstract_inverted_index.overcome | 60 |
| abstract_inverted_index.produced | 28 |
| abstract_inverted_index.provides | 73 |
| abstract_inverted_index.receptor | 2 |
| abstract_inverted_index.cells.CAR | 23 |
| abstract_inverted_index.effective | 52 |
| abstract_inverted_index.improving | 92 |
| abstract_inverted_index.promising | 9 |
| abstract_inverted_index.recognize | 19 |
| abstract_inverted_index.responses | 31, 39 |
| abstract_inverted_index.targeting | 98 |
| abstract_inverted_index.tumors.To | 46 |
| abstract_inverted_index.attenuates | 67 |
| abstract_inverted_index.lymphomas, | 37 |
| abstract_inverted_index.mechanisms | 76 |
| abstract_inverted_index.reprograms | 13 |
| abstract_inverted_index.resistance | 82 |
| abstract_inverted_index.strategies | 90 |
| abstract_inverted_index.lymphocytes | 16 |
| abstract_inverted_index.spectacular | 43 |
| abstract_inverted_index.specifically | 18 |
| abstract_inverted_index.function.This | 71 |
| abstract_inverted_index.immunotherapy | 11 |
| abstract_inverted_index.lymphoblastic | 34 |
| abstract_inverted_index.microenvironment | 64 |
| abstract_inverted_index.immune-suppressive | 62, 99 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5077161506 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 3 |
| corresponding_institution_ids | https://openalex.org/I31746571, https://openalex.org/I4210125633 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.5699999928474426 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.44379784 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |